For The Better

Trupanion continues to compound its revenue at a high rate in an industry with a promising growth outlook.

The biotech is already hard at work developing a vaccine against the worrisome omicron variant.

These investments seem pretty vulnerable right now.

These two stocks have the potential to surprise investors next year.

After five years in the wilderness, LendingClub is back and better than ever.

The online dating company hops aboard the metaverse bandwagon.

The fintech has been a great performer, but could its recent pullback be an opportunity?

It doesn’t take a lot to own a piece of these rapidly growing healthcare businesses.

The internet’s favorite stock picker has been very busy.

Now that it has scrapped iBuying, is it worth keeping Zillow in your portfolio?

The design software company still isn’t growing into its valuations.

This puts Moderna to a crucial test.

The deployment of 5G networks will be a tailwind for this tech stock in the long run.

Clearly, medical expenses are throwing a lot of seniors for a financial loop.

Avalanche could be the next Ethereum.

All the elements are in place for a rebound.

Yes, but with some major caveats.

It’s easy to make money when you buy high-quality stocks and allow time to be your ally.

You can make the leap from index investing to buying individual stocks if you’ve got a solid foundation in place.

Despite substantial sell-offs, Shiba Inu is one of the biggest winners ever. What comes next?